Diseases, Conditions, Syndromes

WHO says not to use ivermectin on COVID-19 patients

The World Health Organization said Wednesday that ivermectin—touted by some on social media as a COVID-19 "miracle cure"—should not be used to treat coronavirus patients.

Medications

EU advises against using drug ivermectin for COVID

The EU's medicines regulator on Monday advised against using the anti-parasite drug ivermectin for coronavirus outside clinical trials, despite headlines touting it as a miracle cure.

Medications

Researchers call for access to Ivermectin for young children

Millions of children weighing less than 15kg are currently denied access to Ivermectin treatment due to insufficient safety data being available to support a change to the current label indication. The WorldWide Antimalarial ...

Medications

Ivermectin does not speed symptom resolution in mild COVID-19

(HealthDay)—A five-day course of ivermectin does not improve the time to resolution of symptoms compared with placebo for adults with mild COVID-19, according to a study published online March 4 in the Journal of the American ...

Medications

S.Africa revokes ivermectin ban, allows 'controlled' human use

South Africa's health products regulator on Wednesday approved the "controlled" use of anti-parasitic agent ivermectin on humans, reversing a decision to ban the drug last month over unproven claims that it can treat COVID-19.

Medical research

New therapeutic approaches for SARS-CoV-2

Medicine has two things to offer when viral pandemics hit: vaccines and therapeutics. While it is hard to undervalue the noble goal of rapidly developing and rolling out safe vaccines that effectively reduce disease severity, ...

Medications

New study to assess the efficacy of ivermectin against COVID-19

Clínica Universidad de Navarra and the Barcelona Institute for Global Health (ISGlobal), a centre supported by the "la Caixa" Foundation, have launched a clinical trial to investigate the efficacy of ivermectin against COVID-19. ...

page 1 from 3

Ivermectin

Ivermectin (22,23-dihydroavermectin B1a + 22,23-dihydroavermectin B1b) is a broad-spectrum antiparasitic avermectin medicine.

It is sold under brand names Stromectol in the United States, Ivomec in Europe by Merial Animal Health, Mectizan in Canada by Merck and Ivexterm in Mexico by Valeant Pharmaceuticals International. While in development, it was assigned the code MK-933 by Merck.

This text uses material from Wikipedia, licensed under CC BY-SA